Efficacy and safety of drug-eluting stents in ST-segment elevation myocardial infarction: a meta-analysis of randomized trials
Format: | text |
---|---|
Language: | eng |
Published: |
Emerald
2010
|
Similar Items
-
Everolimus-eluting bioresorbable stent vs. durable polymer everolimus-eluting metallic stent in patients with ST-segment elevation myocardial infarction: results of the randomized ABSORB ST-segment elevation myocardial infarction—TROFI II trial
by: Sabaté, Manel, et al.
Published: (2016) -
Factors Associated with the Use of Drug-Eluting Stents in Patients Presenting with Acute ST-Segment Elevation Myocardial Infarction
by: Chavez, Jose F., et al.
Published: (2015) -
Everolimus- and sirolimus-eluting stents in patients with and without ST-segment elevation myocardial infarction
by: Velders, M. A., et al.
Published: (2014) -
Clinical outcomes of drug-eluting stent use in patients with ST elevation myocardial infarction
by: Gurvitch, R., et al.
Published: (2010) -
Long-term Outcomes of Drug-eluting versus Bare-metal stent for
ST-elevation Myocardial Infarction
by: Wang, Liping, et al.
Published: (2014)